Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Nyxoah S.A. (NYXH.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
6.63-0.32 (-4.60%)
At close: 05:29PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.95
Open6.96
BidN/A x N/A
AskN/A x N/A
Day's Range6.61 - 7.19
52 Week Range6.61 - 25.90
Volume4,793
Avg. Volume6,011
Market Cap171.295M
Beta (5Y Monthly)0.73
PE Ratio (TTM)N/A
EPS (TTM)-1.16
Earnings DateNov 09, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NYXH.BR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference

      Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference Mont-Saint-Guibert, Belgium – August 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the 17th Annual Wells Fargo Securities Healthcare Conference, which takes p

    • Zacks

      Wall Street Analysts Believe Nyxoah SA (NYXH) Could Rally 170%: Here's is How to Trade

      The mean of analysts' price targets for Nyxoah SA (NYXH) points to a 170.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

    • Motley Fool

      Nyxoah S.A. (NYXH) Q2 2022 Earnings Call Transcript

      Participating from the company today will be Olivier Taelman, chief executive officer; and Loic Moreau, chief financial officer. During the call, we will discuss our operating activities and review our second quarter financial results released after U.S. Before we begin, I would like to remind you that any statements that relate to expectations or predictions of future events, market trends, results or performance are forward-looking statements.

    Advertisement
    Advertisement